Your browser doesn't support javascript.
loading
Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study.
Matsuoka, Katsuyoshi; Hisamatsu, Tadakazu; Mikami, Yohei; Yamamoto, Takayuki; Motoya, Satoshi; Shinzaki, Shinichiro; Iwakiri, Ryuichi; Sugiura, Kenkichi; Nishimura, Kunihiko; Kajita, Mika; Fernandez, Jovelle L.
  • Matsuoka K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Sakura Medical Center, 564-1 Shimoshizu, Sakura, Chiba, 285-8741, Japan. matsuoka@fk2.so-net.ne.jp.
  • Hisamatsu T; Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Mikami Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Yamamoto T; Inflammatory Bowel Disease Center and Department of Surgery, Yokkaichi Hazu Medical Center, Mie, Japan.
  • Motoya S; Department of Gastroenterology and Hepatology (IBD Center), Hokkaido Prefectural Welfare Federation of Agricultural Cooperative, Sapporo-Kosei General Hospital, Hokkaido, Japan.
  • Shinzaki S; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Iwakiri R; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Sugiura K; Statistical and Quantitative Sciences, Takeda Pharmaceutical Company Limited, Osaka, Japan.
  • Nishimura K; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Kajita M; PMS Operations, Bristol Myers Squibb Company, Tokyo, Japan.
  • Fernandez JL; Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
Adv Ther ; 40(6): 2902-2914, 2023 06.
Article en En | MEDLINE | ID: mdl-37140705

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Screening_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Screening_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article